Nonpharmacologic and Pharmacologic Management of Acute Pain From Non-Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of Family Physicians.


Journal

Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351

Informations de publication

Date de publication:
03 11 2020
Historique:
pubmed: 18 8 2020
medline: 7 1 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

The American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) developed this guideline to provide clinical recommendations on nonpharmacologic and pharmacologic management of acute pain from non-low back, musculoskeletal injuries in adults in the outpatient setting. The guidance is based on current best available evidence about benefits and harms, taken in the context of costs and patient values and preferences. This guideline does not address noninvasive treatment of low back pain, which is covered by a separate ACP guideline that has also been endorsed by AAFP. This guideline is based on a systematic evidence review on the comparative efficacy and safety of nonpharmacologic and pharmacologic management of acute pain from non-low back, musculoskeletal injuries in adults in the outpatient setting and a systematic review on the predictors of prolonged opioid use. We evaluated the following clinical outcomes using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system: pain (at ≤2 hours and at 1 to 7 days), physical function, symptom relief, treatment satisfaction, and adverse events. The target audience is all clinicians, and the target patient population is adults with acute pain from non-low back, musculoskeletal injuries.

Identifiants

pubmed: 32805126
doi: 10.7326/M19-3602
doi:

Substances chimiques

Analgesics, Opioid 0
Anti-Inflammatory Agents, Non-Steroidal 0

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

739-748

Investigateurs

Timothy J Wilt (TJ)
Devan L Kansagara (DL)
Pelin Batur (P)
Thomas G Cooney (TG)
Mary Ann Forciea (MA)
Carolyn J Crandall (CJ)
Nick Fitterman (N)
Lauri A Hicks (LA)
Carrie Horwitch (C)
Jennifer S Lin (JS)
Michael Maroto (M)
Robert M McLean (RM)
Reem A Mustafa (RA)
Jeffrey Tice (J)
Janice Tufte (J)
Sandeep Vijan (S)
John W Williams (JW)
Scott Hartman (S)
Gregory Blake (G)
Susan Chiarito (S)
Erin Clark (E)
Sarah Coles (S)
Shannon Connolly (S)
Syeachia Dennis (S)
Kenneth Fink (K)
Lynn Fisher (L)
Beth Anne Fox (BA)
Monica Fudala (M)
Neeta Goel (N)
Brian Hunsicker (B)
Christen Johnson (C)
Eleanor Lavadie-Gomez (E)
Darlene Lawrence (D)
Corey Lyon (C)
Kevin Martin (K)
James A Mobley (JA)
Denee J Moore (DJ)
Jeffrey Quinlan (J)
Elizabeth Roll (E)
Rita Schindeler-Trachta (R)
Alexis Vosooney (A)

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : ErratumIn

Auteurs

Amir Qaseem (A)

American College of Physicians, Philadelphia, Pennsylvania (A.Q.).

Robert M McLean (RM)

Yale School of Medicine, New Haven, Connecticut (R.M.M.).

David O'Gurek (D)

Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania (D.O.).

Pelin Batur (P)

Cleveland Clinic, Cleveland, Ohio (P.B.).

Kenneth Lin (K)

Georgetown University Medical Center, Washington, DC (K.L.).

Devan L Kansagara (DL)

Portland VA Medical Center, Portland, Oregon (D.L.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH